Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-24 @ 3:43 PM
NCT ID:
NCT01463592
Eligibility Criteria:
Inclusion Criteria:
* Following groups of the people will be enrolled for the study.
* Patients suffering from chronic HCV infection as evident with a positive serology for Anti HCV antibody and raised ALT.
* Both males and females
* Age group: 18 - 55 years
* Informed consent
Exclusion Criteria:
* Following groups of people will be excluded from the study
* Pregnant females
* Body mass index more than 25
* Uncontrolled Diabetes Mellitus, Hypertension, Ischemic heart disease, Renal failure, Respiratory failure, Chronic infections, gall stone disease or renal stone disease.
* Patients known to have hypersensitivity to Iodine compounds in the past.
* Psychiatric disorders except mild anxiety disorders.
* Patients suffering from auto immune diseases e.g. Rheumatoid Arthritis, SLE, or thyroid diseases.
* Patients suffering from concomitant HBV infection, HIV infection or any other chronic liver disease.
* Bilirubin more than 2mg/dl, Albumin less than 3.0 gms/dl, INR more than 1.5, Hb. less than 10 gms /dl, absolute neutrophil count less than 1500/cmm and platelet count less than 100,000/cmm
* Serum sodium less than 130mmol/l.
* Patients who have received the interferon treatment in the past.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT01463592
Study Brief:
Protocol Section:
NCT01463592